NEFROSOVET, Moscow

Accounting reports

Previously








Share:
Name
MEDITSINSKOE CHASTNOE UCHREZHDENIE "NEFROSOVET"
INN
7730184402
KPP
773001001
OGRN
1117799013067
OKPO
34456390
Address
121096, G.MOSKVA, ul. Vasilisy kozhinoy, d. 13, pomesch. 1151
Phone
+7 (495) 933-72-42

Extract from EGRUL $12 (€10)

Last name, first name & patronymic of the General Director

List of founders

Position of the company

Licenses

Authorized capital

Branches

Complete structure of the extract
We guarantee to provide you with an actual
information extract

Data on types of economic activities
NEFROSOVET according to EGRUL

OKVED codeTypeName of activity type
86Core activityHealth service
82.99Additional activityOther business support services to businesses and individuals not otherwise specified
85.23Additional activity Training of highly qualified personnel
All types of activities
85.42.9Additional activity Activities for additional professional education, not included in other categories
87Additional activityResidential care activities for mental retardation, mental health and substance abuse
88Additional activitySocial work activities without accommodation
Registration date
08.07.2011
Registering department
Upravlenie Federal'noy nalogovoy sluzhby po g.Moskve

NEFROSOVET (Moscow; INN 7730184402) was registered on 8 Jul 2011. Type of ownership of NEFROSOVET - Private enterprises.

Form of ownership of NEFROSOVET - Private property.

Principal activities of NEFROSOVET: health service (86), other business support services to businesses and individuals not otherwise specified (82.99), training of highly qualified personnel (85.23).

Economic indicators

2024

Net profit (RAS) of NEFROSOVET grew over 2024 28.78 times to 221.34 million RUB from 7.69 million RUB over 2023, the company informed.

Revenue decreased in the accounting period 518.53 times to 5.90 million RUB from 3.06 billion RUB in 2023; cost of goods sold decreased 254.03 times to 11.22 million RUB from 2.85 billion RUB; sales loss made up 6.11 million RUB compared to sales profit of 56.04 million RUB.

2022

Net loss (RA) of NEFROSOVET made up 43.99 million RUB over 2022 compared to net profit of 13.88 million RUB over 2021, the company informed.

Revenue increased in the accounting period by 2.69% to 2.85 billion RUB from 2.77 billion RUB over 2021; cost of goods sold grew by 3.38% to 2.80 billion RUB from 2.71 billion RUB; sales loss grew 82.48 times to 16.74 million RUB from 203.00 thousand RUB.

2021

Net profit (RAS) of NEFROSOVET made up 11.07 million RUB over 2021 compared to net loss of 129.87 million RUB over 2020, the company informed.

Revenue increased in the accounting period by 4.96% to 2.77 billion RUB from 2.64 billion RUB over 2020; cost of goods sold grew by 0.95% to 2.71 billion RUB from 2.69 billion RUB; sales profit made up 1.43 million RUB compared to sales loss of 123.94 million RUB.

2020

Net loss (RA) of NEFROSOVET made up 127.27 million RUB over 2020 compared to net profit of 7.05 million RUB over 2019, the company informed.

Revenue remained in the accounting period at the same level and made up 2.64 billion RUB compared to 2.65 billion RUB 2.65 billion RUB; cost of goods sold grew by 3.85% to 2.71 billion RUB from 2.61 billion RUB; sales loss made up 122.12 million RUB compared to sales profit of 13.20 million RUB.

2018

Net loss (RA) of NEFROSOVET made up 116.23 million RUB over 2018 compared to net profit of 5.17 million RUB over 2017, the company informed.

Revenue increased in the accounting period by 3.51% to 2.56 billion RUB from 2.47 billion RUB over 2017; cost of goods sold grew by 8.34% to 2.66 billion RUB from 2.46 billion RUB; sales loss made up 104.25 million RUB compared to sales profit of 13.83 million RUB.

2017

Net profit (RAS) of NEFROSOVET made up 5.17 million RUB over 2017 compared to net loss of 99.89 million RUB over 2016, the company informed.

Revenue increased in the accounting period by 20.67% to 2.47 billion RUB from 2.05 billion RUB over 2016; cost of goods sold grew by 14.60% to 2.46 billion RUB from 2.14 billion RUB; sales profit made up 13.84 million RUB compared to sales loss of 96.35 million RUB.

2016

Net loss (RAS) of NEFROSOVET increased by 7.40% to 98.97 million RUB from 92.16 million RUB over 2015, the company informed.

Revenue increased in the accounting period by 32.05% to 2.05 billion RUB from 1.55 billion RUB over 2015; cost of goods sold grew by 30.86% to 2.14 billion RUB from 1.64 billion RUB; sales loss grew by 9.71% to 96.35 million RUB from 87.83 million RUB.

2014

Revenue increased in the accounting period 34.60 times to 992.50 million RUB from 28.69 million RUB over 2013; cost of goods sold grew 34.37 times to 986.01 million RUB from 28.69 million RUB.

2013

Net profit (RAS) of CHU Mediko-obrazovatelnaya organizatsiya NES made up 0 RUB over 2013 compared to 9.00 thousand RUB over 2012, the company informed.

Revenue increased in the accounting period 5.65 times to 28.69 million RUB from 5.08 million RUB over 2012; cost of goods sold grew 5.95 times to 28.69 million RUB from 4.82 million RUB; sales profit made up 0 RUB compared to 11.00 thousand RUB.

2012

Net loss (RAS) of CHU Mediko-obrazovatelnaya organizaciya NEHS dropped over 2012 123.38 times to 16.00 thousand RUB from 1.97 million RUB KAgent.Entities.Balance, the company informed.

Cost of goods sold grew 2.57 times to 5.07 million RUB from 1.97 million RUB.




Daily subscription $39 (€32)

unlimited access to database "Kontragent"

download any information within 24 hours

Companies in the region

Guarantees

Guarantees
We guarantee
provision of
relevant
information

Payment methods


Statistics
Companies
12 465 791
Reports
17 430 537
Rrocessed requests
Extract from EGRUL:
Today, 11:33 AM
Accounting reports:
Today, 11:32 AM
The site can contain materials of 16+ category
info@k-agent.ru
Рейтинг@Mail.ru
© "Info-RL", 2006—2025
About the project    Legal basis
Business Business Services Others Info-RL, ООО
Moscow ul. Kazakova, d. 3, str. 4 105064
+7(495) 729−17−96 7 days a week info@k-agent.ru